DORIBAX Trademark

Trademark Overview

On Monday, July 9, 2007, a trademark application was filed for DORIBAX with the United States Patent and Trademark Office. The USPTO has given the DORIBAX trademark a serial number of 76679238. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2019. This trademark is owned by JOHNSON & JOHNSON. The DORIBAX trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals, namely, anti-infectives
doribax

General Information

Serial Number76679238
Word MarkDORIBAX
Filing DateMonday, July 9, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2019
Registration Number3587574
Registration DateTuesday, March 10, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2007

Trademark Statements

Goods and ServicesHuman pharmaceuticals, namely, anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2019
Primary Code005
First Use Anywhere DateMonday, October 15, 2007
First Use In Commerce DateMonday, October 15, 2007

Trademark Owner History

Party NameSHIONOGI & CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressCHUO-KU, OSAKA 541-0045
JP
Party NameJOHNSON & JOHNSON
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Friday, October 11, 2019CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, March 10, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 22, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 22, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 21, 2016TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, October 21, 2015POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, February 4, 2015POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, February 3, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 2, 2015TEAS SECTION 7 REQUEST RECEIVED
Friday, January 30, 2015TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 8, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 10, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, February 5, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, February 3, 2009ASSIGNED TO LIE
Wednesday, January 21, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 15, 2009STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 14, 2009USE AMENDMENT FILED
Wednesday, January 14, 2009TEAS STATEMENT OF USE RECEIVED
Monday, August 11, 2008EXTENSION 1 GRANTED
Thursday, July 31, 2008EXTENSION 1 FILED
Monday, August 11, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 31, 2008TEAS EXTENSION RECEIVED
Tuesday, February 5, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2007NOTICE OF PUBLICATION
Tuesday, October 9, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 9, 2007ASSIGNED TO LIE
Monday, September 10, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 4, 2007ASSIGNED TO EXAMINER
Tuesday, July 17, 2007APPLICATION FILING RECEIPT MAILED
Friday, July 13, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

doribax infectives anti namely pharmaceuticals human